Sign in

CIK 0002035832 · <br>Emerging growth company

Aktis Oncology, Inc.

Sign in to watch
Ticker
AKTS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
852584233
Phone
978-237-4380
Business address
17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA, 02210
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. EFFECT Other Notice of Effectiveness
  8. CERT Other Certification
  9. 8-A12B Other Registration of Securities
  10. DRS/A Other Draft Registration Statement
  11. DRS/A Other Draft Registration Statement
  12. DRSLTR Other Correspondence Related to Draft Registration Statement
  13. DRS/A Other Draft Registration Statement
  14. DRSLTR Other Correspondence Related to Draft Registration Statement
  15. DRS/A Other Draft Registration Statement
  16. DRS Other Draft Registration Statement
  17. D Other Notice of Sales of Unregistered Securities

Page 1 of 1 · 17 filings